We help pharmaceutical, biotechnology, medical device and diagnostics companies build stronger brands through commercial strategy, scientific communications, market research and HCP engagement.
One team across brand strategy, medical communications, market research and commercial execution. Built for how life sciences brands are actually reviewed, launched and grown.
Positioning, messaging and brand architecture that differentiate your asset and hold up in front of medical, legal and regulatory review.
Campaigns and omnichannel journeys designed around how physicians actually seek, weigh and act on clinical information.
Go-to-market strategy, launch sequencing and market shaping built around your evidence, label and access realities.
Scientific content, publications support and medical education written by people who read the studies. Clear, compliant and credible to clinicians.
Primary and secondary research that grounds positioning, segmentation and launch decisions in real market evidence.
Key opinion leader mapping, advisory boards and roundtables that build genuine scientific advocacy for your brand.
Booth strategy, symposia planning and pre- and post-congress engagement that convert conversations into commercial momentum.
Sales enablement, field force marketing support and lifecycle brand management that keep commercial teams sharp between launches.
We do not do restaurants, real estate or retail. Life sciences and healthcare only, which is exactly why the work lands.
Multiplier Solutions is a boutique healthcare marketing and commercial strategy consultancy. We work with pharmaceutical, biotechnology, medical device and diagnostics companies to turn scientific value into commercial results: sharper positioning, stronger HCP relationships and launches that land.
Our teams combine life sciences backgrounds with commercial strategy experience. That means the work starts from the science — the mechanism, the evidence, the label — and is shaped by how brands are actually reviewed, funded and adopted across the US, the UK and India. Strategy first, then creative, then disciplined execution.
Strategists and writers with life sciences backgrounds. We speak mechanism of action, endpoints and access, so your medical reviewers spend less time correcting and more time approving.
Every engagement starts with the commercial question: the market, the competition, the evidence and the path to adoption. Creative follows strategy, never the other way around.
We translate complex clinical evidence into narratives that respect the science and still persuade. Credible to clinicians, clear to committees, compelling to the market.
Work built for medical, legal and regulatory review from the first draft. Documented processes and privacy-compliant operations, ready for procurement and compliance scrutiny.
Market, competitors, HCP behavior and your evidence base. We start with what is true.
Positioning, audiences, channels and the commercial case. Agreed before a single asset is built.
Campaigns, content and materials built for medical review, then built to persuade.
Coordinated activation across channels, congresses and field teams.
Regular performance reviews with your commercial team. Learnings compound into the next quarter.
Client identities are confidential by agreement. Metrics shown are illustrative placeholders pending verified figures.
Launch positioning, HCP campaign development and market shaping across priority geographies, built on validated physician insight.
Category positioning, congress-led demand generation and structured follow-up aimed at hospital decision-makers.
Scientific storytelling, KOL-led education and awareness content that lifted disease recognition among target clinicians.
Sample quotes for layout only. Replace with approved client testimonials and names before publishing.
They understood our therapy area before the kickoff call ended. Medical review cycles dropped from weeks to days.
VP, Commercial Excellence placeholder
Global pharmaceutical companyThe first agency that tied every activity to a commercial outcome we could take to leadership. The board noticed.
Chief Marketing Officer placeholder
US MedTech companyCongress season used to be a cost center. This year it produced our strongest quarter of HCP relationships on record.
Brand Lead, Medical Affairs placeholder
Biotechnology companySchedule a 20-minute consultation. Bring your hardest commercial problem: a launch, a stalled brand, an HCP audience that will not engage. We will bring a point of view, not a pitch deck.